Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sigmart in Recurrent Angina After Coronary Revascularization
NCT01185015Phase 4Withdrawn
- Sponsor
- Merck KGaA
- Start
- Jan 2011
- Primary completion
- Jan 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of nicorandil in angina pectoris, sponsored by Merck KGaA. Planned start Jan 2011; status: withdrawn.
02
Drugs
nicorandil
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT01185015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185015.